1.Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Fitridge R, Game F, et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev 2024;40:e3657.
2.Pavicic T, Korting HC. Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management. J Dtsch Dermatol Ges 2006;4:935-41.
3.Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367-75.
4.Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, et al. Lower extremity ampu-tations - a review of global variability in incidence. Diabet Med 2011;28:1144-53.
5.Bus SA, Sacco ICN, Monteiro-Soares M, Raspovic A, Paton J, Rasmussen A, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev 2024;40:e3651.
6.Han SGManagement of diabetic wound. Paju: Koonja; 2008.
7.Rayman G, Vas PR, Baker N, Taylor CG Jr, Gooday C, Alder AI, et al. The Ipswich touch test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 2011;34:1517-8.
8.Kozol RA, Bredenberg CE, Fey JD, Oates RP. Dependent rubor as a predictor of limb risk in patients with claudication. Arch Surg 1984;119:932-5.
9.Yang JP, Lee YN, Son JW, Han SK. The impact of extracorporeal shock wave therapy on microcirculation in diabetic feet: a pilot study. Adv Skin Wound Care 2019;32:563-7.
11.Baird SA, Skinner CM, Trail S, Frankis JS. Anhydrosis in the diabetic foot: a comparison of two urea creams. Diabetic Foot J 2003;6:122-36.
12.Aan de Stegge WB, Mejaiti N, van Netten JJ, Dijkgraaf MGW, van Baal JG, Busch-Westbroek TE, et al. The cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes (DIATEMP): study protocol for a randomized controlled trial. Trials 2018;19:520.
13.Arts ML, Waaijman R, de Haart M, Keukenkamp R, Nollet F, Bus SA. Offloading effect of therapeutic footwear in patients with diabetic neuropathy at high risk for plantar foot ulceration. Diabet Med 2012;29:1534-41.
16.Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996;13:979-82.
19.Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupi-ter DC. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg 2016;55:591-9.
20.Rastogi A, Goyal G, Kesavan R, Bal A, Kumar H, Man-galanadanam , et al. Long term outcomes after incident diabetic foot ulcer: multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: epidemiology of diabetic foot complications study. Diabetes Res Clin Pract 2020;162:108113.
23.Schmidt BM, Holmes CM, Najarian K, Gallagher K, Haus JM, Shadiow J, et al. On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clin-ical needs. J Diabetes Complications 2022;36:108317.
25.Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000;16(Suppl 1):S75-83.